Showing results (121-130 of 281) with videos related to
Sort By:
Pageof 29
American Heart Journal|May 16, 2016
Ischemic cardiac outcomes and hospitalizations according to prior macrovascular disease status in patients with type 2 diabetes and recent acute coronary syndrome from the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care trialYuichi J Shimada, Christopher P Cannon, Yuyin Liu, et al.Journal of the American Society of Hypertension : JASH|December 13, 2016
Electrocardiographic measures of left ventricular hypertrophy in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack TrialMichael E Ernst, Barry R Davis, Elsayed Z Soliman, et al.Journal of the American Heart Association|January 30, 2026
Per-Protocol Analysis of Chlorthalidone Versus Hydrochlorothiazide for Cardiovascular Event Prevention-Diuretic Comparison ProjectSonia T Anand, Cynthia Hau, Michael J Davenport, et al.Journal of Pharmaceutical Health Services Research : an Official Journal of the Royal Pharmaceutical Society of Great Britain|July 22, 2014
Potential effects of racial and ethnic disparities in meeting Medicare medication therapy management eligibility criteriaJunling Wang, Yanru Qiao, Ya-Chen Tina Shih, et al.Circulation|March 2, 2017
Serial Measurement of High-Sensitivity Troponin I and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus in the EXAMINE Trial (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care)Matthew A Cavender, William B White, Petr Jarolim, et al.Circulation|January 30, 2002
Fosinopril versus amlodipine comparative treatments study: a randomized trial to assess effects on plasminogen activator inhibitor-1Marco Pahor, Lonneke V Franse, Steven R Deitcher, et al.Journal of the National Medical Association|October 9, 2017
Influence of Prevalent and Incident Atrial Fibrillation on Post-Trial Major Events in ALLHATL Julian Haywood, Barry R Davis, Linda B Piller, et al.The Lancet. Neurology|June 21, 2020
Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trialTali Cukierman-Yaffe, Hertzel C Gerstein, Helen M Colhoun, et al.Journal of Managed Care & Specialty Pharmacy|November 2, 2015
Potential Health Implications of Medication Therapy Management Eligibility Criteria in the Patient Protection and Affordable Care Act Across Racial and Ethnic GroupsJunling Wang, Yanru Qiao, Ya-Chen Tina Shih, et al.The American Journal of Cardiology|July 12, 2007
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trialWilliam C Cushman, Richard H Grimm, Jeffrey A Cutler, et al.Pageof 29